English
Lycia Therapeutics, Inc.
EDGARMarket value is not computed: no listed ticker is recorded for this company.
1 filing records in this dataset, filed from 2026-10-05 to 2026-10-05. Explore the available filing history and original sources.
Holdings and insider activity
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-18.
- Open-market purchases (code P)
- 12 transactions, 2,078,749 shares
- Sum of shares × price per share: 38,522,394.33
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
- 2026-11-02 Venrock Healthcare Capital Partners III, L.P. P 8,305 26.95
- 2026-10-30 Venrock Healthcare Capital Partners III, L.P. P 8,804 26.27
- 2026-10-30 Venrock Healthcare Capital Partners III, L.P. P 200 26.86
- 2026-10-29 Venrock Healthcare Capital Partners III, L.P. P 1,000 26.33
- 2026-10-28 Venrock Healthcare Capital Partners III, L.P. P 10,570 25.23
5% holders (Schedule 13D and 13G)
- Venrock Healthcare Capital Partners III, L.P. 11.9% SCHEDULE 13G 10/23/2026
- VHCP Co-Investment Holdings III, LLC 11.9% SCHEDULE 13G 10/23/2026
- Venrock Healthcare Capital Partners EG, L.P. 11.9% SCHEDULE 13G 10/23/2026
Registration statement
This company has filed to register securities with the SEC and has not yet filed an annual or quarterly report. Its financial statements are in the filing itself rather than structured data, so reported figures appear here once periodic reports are filed.
- Registration statement (S-1) · filed 2026-10-05 Open filing documents
Offering terms · S-1 · 2026-10-05
- Security
- Common stock, par value $0.0001 per share
- Maximum offering price
- USD 100,000,000
- Registration fee
- USD 8,700 · 0.0087%
The maximum offering price is the amount the registration fee is computed on, not what the company expects to raise. The offering size and price range are in the prospectus.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
1 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001806540, 1806540, edgar:1806540
Also known as Lycia Therapeutics, Inc.